comparemela.com
Latest Breaking News On - Prnewswire wellmarker bio co ltd - Page 1 : comparemela.com
Wellmarker Bio Announces Clinical Trial Collaboration with MSD to evaluate WM-A1-3389 in combination with KEYTRUDA® (pembrolizumab)
Wellmarker Bio is pleased to sign a clinical collaboration and supply agreement with MSD (Merck & Co., Inc., Rahway, NJ, USA) to evaluate a first-in-class treatment with a novel mechanism in
Seoul
Soult-ukpyolsi
South-korea
United-states
Korea
Dong-hoon-jin
Wellmarker-bio
Schwierige-zeiten
Ulsan-college-of-medicine
Pharmaventures-ltd
Pharmaventures-capital-ltd
Prnewswire-wellmarker-bio-co-ltd
vimarsana © 2020. All Rights Reserved.